MYMD Projected Dividend Yield
MyMD Pharmaceuticals Inc ( NASDAQ : MYMD )MyMD Pharmaceuticals is a clinical stage pharmaceutical company. Co. is focused on developing and commercializing two therapeutic platforms based on therapeutic targets, MYMD-1 and Supera-CBD. MYMD-1 is a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease and is being developed to treat age-related illnesses. Supera-CBD is a synthetic analog of cannabidiol being developed to treat various conditions, including epilepsy, pain and anxiety/depression, through its effects on the CB2 receptor, opioid receptors and monoamine oxidase enzyme type B. 20 YEAR PERFORMANCE RESULTS |
MYMD Dividend History Detail MYMD Dividend News MYMD Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |